reproductive-health

The Medical News

Women on menopausal hormonal therapy face a decreased risk of low bone mineral density compared to those not using it, according to a study being presented Sunday at ENDO 2026, the Endocrine Society's annual meeting in Chicago, Ill.

medicinereproductive-health
The Medical News

The first real-world study of the FDA-approved non-hormone treatment fezolinetant found the menopausal medication improved hot flashes, depression and anxiety in women, according to industry-sponsored research being presented Sunday at ENDO 2026, the Endocrine Society's annual meeting in Chicago, Ill.

medicinereproductive-health
Newswise: Latest News

The first real-world study of the FDA-approved non-hormone treatment fezolinetant found the menopausal medication improved hot flashes, depression and anxiety in women, according to industry-sponsored research being presented Sunday at ENDO 2026, the Endocrine Society's annual meeting in Chicago, Ill.

medicinepharmacologyreproductive-health
GeekWire
bionity.com News
The Guardian

More women are rejecting state pressure over their reproductive choices, amid the devastating legacy of the one-child policy Ever since the founding of the People’s Republic of China in 1949, women’s bodies have been the business of the state. In the 1950s, labour for state-controlled work units was organised according to women’s menstrual cycles. Then for decades, there was the one-child policy.…

medicinereproductive-health
The Medical News

Samantha Parker Kelleher, along with researchers at BU School of Public Health and Boston Medical Center, will examine the role of high blood pressure during the postpartum period on the risk of developing recurrent hypertensive disorders of pregnancy, such as preeclampsia and gestational hypertension.

epidemiologymedicinepublic-healthreproductive-health
MIT Department of Materials Science and Engineering
Newswise: Latest News

-- Endometriosis and uterine fibroids are two of the most common gynecological conditions. While they have important differences, they also have things in common. Both can lead to serious complications, affect fertility and have symptoms related to the menstrual cycle. And both are the focus of medical innovations to give women better treatment options, explains Megan Wasson, D.O., a gynecologist…

medicinereproductive-health
Nature Cell Biology

Nature Cell Biology, Published online: 11 June 2026; doi:10.1038/s41556-026-01993-x This Perspective highlights the use of current proteomics technologies in defining stage-specific reprogramming events to understand reproductive ageing, improve oocyte quality, and refine the outcomes of assisted reproductive technology (ART).

biologydevelopmental-biologyreproductive-health
Frontiers in Psychology | New and Recent Articles

ObjectiveTo develop a scale to measure fertility social mentality among women of childbearing age in China and to assess its psychometric properties, including reliability, validity, and measurement invariance.MethodsA total of 496, 857, 607, 632 and 362 women of childbearing age were recruited to conduct exploratory factor analysis, reliability and validity testing, and measurement invariance te…

medicinereproductive-health
Center for Reproductive Health Sciences | Washington University in St. Louis

Congratulations to Shweta Bhagwat, PhD, postdoctoral research associate in the lab of Celia Santi, MD, PhD, for recently receiving a prestigious NIH Pathway to Independence Award (K99/R00) for her project titled “Study the impact of Bacterial Vaginosis (BV) toxins on sperm function.” Her research is being funded by the NIH/Eunice Kennedy Shriver National Institute of Child Health and Human Develo…

infectious-diseasemedicinereproductive-health
Frontiers in Psychiatry | New and Recent Articles

BackgroundPostpartum depressive episodes are common. Patients with bipolar disorder (BD) may also experience manic or mixed episodes postpartum, but cases of delirious mania (DM)—characterized by rapidly evolving delirium, mania, and may involve psychotic symptoms—are rarely reported. Given its severity, frequent underdiagnosis, and life-threatening risks, a thorough exploration of its clinical f…

medicinepsychiatryreproductive-health
Frontiers in Reproductive Health | New and Recent Articles

BackgroundDespite national policies promoting adolescent- and youth-friendly health services, implementation gaps hinder improvements in adolescent sexual and reproductive health outcomes in Mozambique. S-NICE is a structured, participatory decision-support intervention designed to strengthen delivery through routine data use, multisectoral coordination, and local action planning. This study eval…

implementation-researchmedicinepublic-healthreproductive-healthsocial-science
Frontiers in Reproductive Health | New and Recent Articles

BackgroundA better understanding of the response of granulosa cells to exogenous hormone stimulation and how this impacts the complex interplay between the granulosa cells and the oocyte is crucial for the optimal management of infertile couples seeking IVF treatment.MethodsGranulosa and cumulus cells (G + CCs) from women with different degrees of ovarian responsiveness to controlled ovarian hype…

bioinformaticsbiologygeneticsmedicinereproductive-health
The Medical News
The Medical News

Researchers at the University of Colorado Anschutz have published a proof-of-concept study in Fertility and Sterility demonstrating that injectable semaglutide may offer meaningful reproductive benefits for women with polyendocrine metabolic ovarian syndrome (PMOS), formerly known as polycystic ovary syndrome (PCOS).

medicinepharmacologyreproductive-health
CU Anschutz Newsroom

Researchers at the University of Colorado Anschutz have published a proof-of-concept study in Fertility and Sterility demonstrating that injectable semaglutide may offer meaningful reproductive benefits for women with polyendocrine metabolic ovarian syndrome (PMOS), f ormerly known as polycystic ovary syndrome (PCOS).

medicinepharmacologyreproductive-health
Latest from Live Science
CU Anschutz Newsroom

When asked if she could walk unassisted after taking part in a clinical trial, Lynn Montgomery-Haga jumps up from her chair and does a quick lap around the tables of her small town’s only coffee shop. At the end, the longtime Milliken, Colo., resident throws her arms in the air, taking a “ta-da!”-like pose. The answer was a definite yes.

gene-therapymedicinereproductive-health
research.ioresearch.io

Sign up to keep scrolling

Create your feed subscriptions, save articles, keep scrolling.

Already have an account?